Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Allstate Corp (ALL) vs BioNTech SE - ADR (BNTX) Price & Performance

Allstate CorpTrade
BioNTech SE - ADRTrade

Price performance (Past 24H)

Key statistics

Allstate Corp vs BioNTech SE - ADR — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Allstate Corp is far larger — about 2.8× BioNTech SE - ADR's market cap, and Allstate Corp pays a 1.65% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

ALLBNTX
Market Cap
$66.31B$23.31B
Sector
FinancialsHealth
52-Week High
$275.11$119.34
52-Week Low
$190.00$83.89
Enterprise Value
$74.96B$6.60B
Dividend Yield
1.65%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Allstate Corp

On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.

Read more on ALL

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX